Better evidence for safety and efficacy is needed before neurologists prescribe drugs for neuroenhancement to healthy people
- PMID: 22007842
- DOI: 10.1080/13554794.2011.588174
Better evidence for safety and efficacy is needed before neurologists prescribe drugs for neuroenhancement to healthy people
Abstract
In this paper we question the guidance offered to neurologists by the Ethics, Law and Humanities Committee of the American Academy of Neurology (Larriviere, Williams, Rizzo & Bonnie, 2009) on how to respond to requests for "neuroenhancement": the use of pharmaceuticals to enhance cognitive function in cognitively normal people. The guidance assumes that the benefits of using neuroenhancers will prove to outweigh the risks in the absence of any evidence that this is the case. However, the principle of nonmaleficence dictates that the use of these drugs by healthy people should not be condoned before reliable evidence for their short and long term safety and efficacy is at hand. The proposed ethical framework for neuroenhancement prescribing also neglects the broader social implications of condoning such practices. The adoption of these guidelines by neurologists could have adverse social and medical effects that need to be more carefully considered.
Similar articles
-
[Neuroenhancement in healthy subject? A French case study].Therapie. 2012 May-Jun;67(3):213-21. doi: 10.2515/therapie/2012026. Epub 2012 Aug 9. Therapie. 2012. PMID: 22874487 French.
-
Cognitive neuroenhancement: false assumptions in the ethical debate.J Med Ethics. 2012 Jun;38(6):372-5. doi: 10.1136/medethics-2011-100041. Epub 2012 Jan 6. J Med Ethics. 2012. PMID: 22228818
-
Efficacy, safety, and ethics of cosmetic neurology far from settled.Clin Pharmacol Ther. 2010 Oct;88(4):461-3. doi: 10.1038/clpt.2010.194. Clin Pharmacol Ther. 2010. PMID: 20856245
-
Pediatric neuroenhancement: ethical, legal, social, and neurodevelopmental implications.Neurology. 2013 Mar 26;80(13):1251-60. doi: 10.1212/WNL.0b013e318289703b. Epub 2013 Mar 13. Neurology. 2013. PMID: 23486879 Review.
-
[Options, limits and ethics of pharmacological neuroenhancement].Nervenarzt. 2010 Jan;81(1):66-74. doi: 10.1007/s00115-009-2858-2. Nervenarzt. 2010. PMID: 19851745 Review. German.
Cited by
-
Navigating the enhancement landscape. Ethical issues in research on cognitive enhancers for healthy individuals.EMBO Rep. 2013 Feb;14(2):123-8. doi: 10.1038/embor.2012.225. Epub 2013 Jan 15. EMBO Rep. 2013. PMID: 23318628 Free PMC article. No abstract available.
-
Pharmacological cognitive enhancement-how neuroscientific research could advance ethical debate.Front Syst Neurosci. 2014 Jun 11;8:107. doi: 10.3389/fnsys.2014.00107. eCollection 2014. Front Syst Neurosci. 2014. PMID: 24999320 Free PMC article.
-
The value and pitfalls of speculation about science and technology in bioethics: the case of cognitive enhancement.Med Health Care Philos. 2014 Aug;17(3):325-37. doi: 10.1007/s11019-013-9539-4. Med Health Care Philos. 2014. PMID: 24402841
-
A pilot placebo-controlled, double-blind, and randomized study on the cognition-enhancing benefits of a proprietary chicken meat ingredient in healthy subjects.Nutr J. 2013 Aug 15;12:121. doi: 10.1186/1475-2891-12-121. Nutr J. 2013. PMID: 23945213 Free PMC article. Clinical Trial.
-
Cochlear Implantation, Enhancements, Transhumanism and Posthumanism: Some Human Questions.Sci Eng Ethics. 2016 Feb;22(1):67-92. doi: 10.1007/s11948-015-9640-6. Epub 2015 May 12. Sci Eng Ethics. 2016. PMID: 25962718
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
